9/18/2025

Novavax, Inc.’s outlook improves with a Sanofi partnership and upgraded 2025 revenue guidance. Click for my updated look at NVAX stock and why I'm upgrading it.

Source: SeekingAlpha

9/15/2025

Explore how President Trump's drug pricing policy impacts pharma stocks like PFE & LLY. Learn investment strategies as regulatory risks rise. Click for more.

Source: SeekingAlpha

9/12/2025

Dow Jones hits record 46,000 amid tech and AI gains. What does this mean for investors for the rest of this year? Read the full analysis here.

Source: SeekingAlpha

9/11/2025

On Wednesday evening, at The Plaza Hotel, American Skin Association (ASA) held their Annual Gala. They presented awards to two outstanding honorees and celebrated another successful year of funding research and educating youth on skin health. The gala was attended by over 300 of ASA's loyal supporters and donors, including philanthropists, business leaders, and renowned physicians from the field of dermatology.

Source: Yahoo

9/11/2025

Sanofi's gene therapy SAR402663 for wet AMD earns FDA fast track status, aiming to speed up development and reduce treatment burden.

Source: Yahoo

9/11/2025

The NMPA's decision follows a priority review recognising Tzield's novel characteristics and advantages for paediatric patients.

Source: Yahoo

9/11/2025

Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration Designation earned for a one-time intravitreal gene therapy with the potential to eliminate treatment burden for people living with neovascular age-related macular degenerationNeovascular or “wet” age-related macular degeneration can lead to significant vision loss and affects more than one million people in the US Paris, September 11, 2025. The US Food and Drug Administration (FDA) has gra

Source: Yahoo

9/11/2025

Private equity firm GTCR has struck a 4.1 billion euro ($4.8 billion) deal to buy Czech generic drugmaker Zentiva from Advent International, the Financial Times reported on Wednesday, citing unidentified sources. Reuters could not immediately confirm the report. GTCR, Advent and Zentiva did not immediately respond to a Reuters request for comment.

Source: Yahoo

9/10/2025

Sanofi is partnering with celebrity moms who chose to immunize their babies with BEYFORTUS® (nirsevimab-alip) to help educate families about the importance of RSV infant protection. BEYFORTUS is the first long-acting monoclonal antibody approved to prevent a serious RSV lung infection in newborns and infants entering their first RSV season, as well as in children up to 24 months of age who remain at risk for severe RSV through their second season. It is the first RSV protection designed for all

Source: Yahoo

9/10/2025

Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes Approval based on the TN-10 study, demonstrating Tzield’s ability to delay the onset of stage 3 T1D in adult and pediatric patients aged eight years and older, with stage 2 T1D compared to placeboAdditional regulatory reviews are ongoing across different disease stages by regulatory authorities around the world Paris, September 10, 2025- The Chinese National Medical Products

Source: Yahoo

9/9/2025

Get the latest insights from Sanofi's CEO on R&D, pipeline assets, U.S.

Source: SeekingAlpha

9/9/2025

Lucem Health, a pioneer in AI-powered early disease detection, today announced the launch of a new program designed to accelerate the identification of individuals at risk for presymptomatic Type 1 Diabetes (T1D). This initiative expands Lucem Health's growing portfolio of AI-powered early detection solutions focused on accelerating disease detection, improving care delivery and enhancing patient outcomes

Source: Yahoo

9/9/2025

CAMBRIDGE, Mass., September 09, 2025--Vyome Holdings, Inc. (NASDAQ: HIND), a clinical-stage healthcare holding company, today announced the appointment of Dr. Richard Fahrner as Chief Technology Officer and Dr. Tamara Agajanov, MD, as Senior Vice President – Clinical Development.

Source: Yahoo

9/9/2025

The concussions market is experiencing significant growth due to increased awareness of the long-term impacts of mild traumatic brain injuries and advancements in diagnostic technology. Fueled by advances like biomarker assays and portable neuroimaging tools, this sector benefits from investments in research and digital health. North America leads the market, backed by robust healthcare infrastructure and strategic regulations. Key players such as Oragenics, Pfizer, and Sanofi are optimizing the

Source: Yahoo

9/8/2025

1149 ET – Wall Street appears downbeat on the latest trial results for Alkermes’ narcolepsy treatment alixorexton, though the data came in largely as expected, according to Mizuho analysts. In the trial, patients with narcolepsy type 1 showed statistically significant improvements depending on the size of the dose they received, and as expected, only one dose was statistically significant to reduce cataplexy, the analysts say in a note. 0432 ET – Sanofi saw weaker-than-expected data on new eczema drug amlitelimab and is facing vaccine headwinds, Intron Health analysts Naresh Chouhan and Dominic Rose write.

Source: Yahoo

9/8/2025

LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved by the U.S. Food and Drug Administration for the treatment of adults with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. This indication was approved based on the pivotal LUNA 3 study.1 “Onco360 is proud to partner

Source: Yahoo

9/8/2025

Shares of Dianthus Therapeutics surged Monday after the company's autoimmune disease treatment succeeded in a midstage study.

Source: Yahoo

9/8/2025

Nektar shares surge 38.2% on investor optimism on rezpeg's potential in atopic dermatitis after upbeat mid-stage study results.

Source: Yahoo

9/8/2025

Alnylam's strong drug sales and advancing partnerships with Regeneron and Roche highlight key growth drivers in the quarters ahead.

Source: Yahoo

9/8/2025

NEW YORK, September 08, 2025--WPIX-TV has renewed its agreement with SNY to air New York Mets games on PIX11 through 2028, with expanded regional coverage on Nexstar stations.

Source: Yahoo